News

Here are a number of compelling reasons to consider seeking out a mentor to help you with your neurology career.

How best ensure an accurate ADHD diagnosis in the absence of an established gold-standard or neuroimaging test or biomarker?

Mentors might be older or younger than their mentees-it’s their experience that matters

The top three reasons for not reporting a concussion was similar between males and females.

May news includes ground-breaking FDA approvals, predictions of Alzheimer disease, and a possible biomarker for mild traumatic brain injury.

Blood protein analysis of plasma total tau has diagnostic use in Alzheimer disease. Could the same hold true for CTE?

April news includes tools to manage brain injury and predict recovery, new drug hits and misses, and an updated epilepsy classification system.

Research presented at IBIA 2017 looked at risk behavior in adolescents, return to work, and maladaptive emotion regulation following TBI.

March news includes possible brain tumor therapies, a study exploring mechanisms underlying demyelination-induced seizures, and VNS post stroke.

January news includes the first FDA-approved drug for spinal muscular atrophy, various epilepsy treatments & vitamin D’s impact on Alzheimer & headache.

From Alzheimer disease to Zika virus, we’ve compiled a list of this year’s most popular articles on Neurology Times.

November news includes the first human clinical trial focusing on tau in Alzheimer disease and Zika-related microcephaly not presenting at birth.

Do lipid-lowering medications or low vitamin D levels in mid-life cause neurocognitive deficits? What effect does hypotension have on TBI outcomes?

November news includes potential Alzheimer treatments, FDA approval of a device to prevent recurrent stroke, & a newly typified headache disorder.

Oct. news includes an approved deep brain stimulation system for movement disorders & biomarkers that improve risk assessment in atrial fibrillation.

Second-impact syndrome remains a hotly debated diagnosis. A recently published case report evoked 3 commentaries from concussion management experts.

Our Sept. news includes a possible clinical marker and therapy target in Alzheimer disease and MS findings from an optical coherence tomography study.

A study of U.S. Armed Forces asks if severity of traumatic brain injury impacts the likelihood of developing headache or migraine.

Our August news includes a potential classification system for Alzheimer disease, new findings in a 3D model of TBI, and migraine treatments.

Recent neurological studies outline a link between TBI and Parkinson disease, discuss neuroimaging to predict recovery, and warn against DIY tDCS.

Our July news includes the Alzheimer-diabetes link, increased rates of Parkinson, and guidelines for acute migraine treatment in the ED.

An experimental device designed to complement a helmet reduces brain slosh during head impact. Can it also prevent a concussion?

Several points relevant to neurology were discussed during a special session on TBI by the Association for Research in Vision and Ophthalmology.

Our May news includes memory replay disruption in Alzheimer disease, impulse control disorder in Parkinson disease, and return to play in TBI.

Does traumatic brain injury (TBI) inevitably lead to psychiatric disorders? Research presented at AAN 2016 aimed to quantify the risk of psychiatric illness after TBI.

Using advanced and traditional MRIs, researchers measured the amount of white matter brain damage in living retired NFL players.

How important do you consider cognitive rest in the management of TBI? How long do you recommend cognitive rest in patients with mild TBI?

Why do you think sports-related concussion rates have increased – growing popularity of sports, improved awareness, better screening and diagnosis?